Skip to main content
Premium Trial:

Request an Annual Quote

Aspera to Provide Data Transfer Infrastructure for NCI-funded Proteomic Consortium


Aspera said this week that it has been tapped by Enterprise Science and Computing, ESAC, to provide high-speed data transfer software for a new proteomics data repository and web portal that's being launched by the Clinical Proteomic Tumor Analysis Consortium, or CPTAC.

ESAC, a provider of research data management, bioinformatics, and healthcare information technology solutions, was awarded a five-year contract by the National Cancer Institute's Office of Cancer Clinical Proteomics Research to manage the launch of a new data coordinating center for the CPTAC.

Under the terms of the contract, ESAC is responsible for developing a data center and two data portals — the first is a private repository for consortium members to upload and download shared data; and the second is a separate public portal through which the scientific community will be able to access the data.

It selected Aspera's Connect Server to enable researchers move large proteomic datasets to and from the data repository quickly and efficiently. Aspera's tools also provide security features such as encryption in transit and at rest as well as data integrity verification for each transmitted block and they enable users transfer data to and from the repositories, with no content loss.

Filed under

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.